CoChat

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis

Open access
Nhu, Nguyen Thi Quynh, Heemskerk, Dorothee, Thu, Do Dang Anh, Chau, Tran Thi Hong, Mai, Nguyen Thi Hoang, Nghia, Ho Dang Trung, Loc, Pham Phu, Ha, Dang Thi Minh, Merson, Laura, Thinh, Tran Thi Van, Day, Jeremy, Chau, Nguyen van Vinh, Wolbers, Marcel, Farrar, Jeremy, Caws, Maxine · 2014 · Journal of Clinical Microbiology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Tuberculous meningitis (TBM) is the most severe form of tuberculosis. Microbiological confirmation is rare, and treatment is often delayed, increasing mortality and morbidity. The GeneXpert MTB/RIF test was evaluated in a large cohort of patients with suspected tuberculous meningitis. Three hundred seventy-nine patients presenting with suspected tuberculous meningitis to the Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam, between 17 April 2011 and 31 December 2012 were included in the study. Cerebrospinal fluid samples were tested by Ziehl-Neelsen smear, mycobacterial growth indicator tube (MGIT) culture, and Xpert MTB/RIF. Rifampin (RIF) resistance results by Xpert were confirmed by an MTBDR-Plus line probe assay and all positive cultures were tested by phenotypic MGIT drug susceptibility testing. Overall, 182/379 included patients (48.0%) were diagnosed with tuberculous meningitis. Sensitivities of Xpert, smear, and MGIT culture among patients diagnosed with TBM were 59.3% (108/182 [95% confidence interval {CI}, 51.8 to 66.5%]), 78.6% (143/182 [95% CI, 71.9 to 84.3%]) and 66.5% (121/182 [95% CI, 59.1 to 73.3%]), respectively. There was one false-positive Xpert MTB/RIF test (99.5% specificity). Four cases of RIF resistance (4/109; 3.7%) were identified by Xpert, of which 3 were confirmed to be multidrug-resistant (MDR) TBM and one was culture negative. Xpert MTB/RIF is a rapid and specific test for the diagnosis of tuberculous meningitis. The addition of a vortexing step to sample processing increased sensitivity for confirmed TBM by 20% ( P = 0.04). Meticulous examination of a smear from a large volume of cerebrospinal fluid (CSF) remains the most sensitive technique but is not practical in most laboratories. The Xpert MTB/RIF represents a significant advance in the early diagnosis of this devastating condition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jcm.01834-13

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Flow chart of diagnosis for patients included in the study, showing final TBM diagnosis and Xpert MTB/RIF results. Neg., negative; pos., positive.
FIG 1 Flow chart of diagnosis for patients included in the study, showing final TBM diagnosis and Xpert MTB/RIF results. Neg., negative; pos., positive.CC BY · PubMed Central
FIG 2 Sensitivity of Xpert MTB/RIF by volume of CSF processed for TB testing.
FIG 2 Sensitivity of Xpert MTB/RIF by volume of CSF processed for TB testing.CC BY · PubMed Central
FIG 3 Sensitivities of ZN smear, MGIT culture, and Xpert MTB/RIF against the clinical gold standard for the diagnosis of TB meningitis in all patients and by HIV status. Values in brackets are 95% confidence intervals.
FIG 3 Sensitivities of ZN smear, MGIT culture, and Xpert MTB/RIF against the clinical gold standard for the diagnosis of TB meningitis in all patients and by HIV status. Values in brackets are 95% confidence intervals.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 3

  1. World Health Organization. 2011. Automated real time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Policy statement. WHO/HTM/TB/2011.4. World Health Organization, Geneva, Switzerland.
  2. Becton Dickinson. 2010. Bactec MGIT SIRE drug kit package insert. Becton Dickinson, Sparks, MD. http://www.bd.com/ds/technicalCenter/inserts/PP118JAA(201006).pdf.
  3. HAIN Lifesciences. 2010. Genotype MTBDRplus package insert. Hain Lifesciences, Nehren, Germany.

Cited by

See all 247

Metadata

Authors
Nhu, N. T. Q., Heemskerk, D., Thu, D. D. A., Chau, T. T. H., Mai, N. T. H., Nghia, H. D. T., Loc, P. P., Ha, D. T. M., Merson, L., Thinh, T. T. V., Day, J., Chau, N. V. V., Wolbers, M., Farrar, J., & Caws, M.
Affiliations
  • Oxford University Clinical Research Unit (VN)
  • Hospital for Tropical Diseases (VN)
  • Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
  • Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam
Corresponding author
Caws, Maxine
Venue
Journal of Clinical Microbiology
Published
2014-01
Volume
52
Issue
1
Pages
226-233
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W2014074083
Cited by
244
References
44
Citations by year
2026: 9 · 2025: 12 · 2024: 16 · 2023: 13 · 2022: 15 · 2021: 20 · 2020: 29 · 2019: 26 · 2018: 33 · 2017: 24 · 2016: 16 · 2015: 15 · 2014: 15
FWCI
15.10
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Clinical Microbiology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Greater South Information System
Funders
Wellcome Trust
Topics
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
Keywords
tuberculous meningitis, Xpert MTB/RIF, rapid molecular diagnostics, rifampicin resistance, multidrug-resistant tuberculosis, cerebrospinal fluid, sensitivity and specificity
MeSH terms
Adult, Aged, Aged, 80 and over, Antitubercular Agents, Cerebrospinal Fluid, False Positive Reactions, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Mycobacterium tuberculosis, Rifampin, Sensitivity and Specificity, Tuberculosis, Meningeal, Vietnam, Molecular Diagnostic Techniques, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis. https://app.cochat.ai/papers/10.1128/jcm.01834-13
The paper
Nhu, N. T. Q., Heemskerk, D., Thu, D. D. A., Chau, T. T. H., Mai, N. T. H., Nghia, H. D. T., Loc, P. P., Ha, D. T. M., Merson, L., Thinh, T. T. V., Day, J., Chau, N. V. V., Wolbers, M., Farrar, J., & Caws, M. (2014). Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01834-13

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.